Clinical Trials Browser

Phase 3 × ABP 501 × Clear all

NCT05073315 2024-02-09

A Comparative Study Between ABP 501 and Humira® in Participants With Moderate to Severe Plaque Psoriasis

Phase 3 Completed

425 enrolled 22 charts

Plaque Psoriasis